SOURCE: Leatt Corporation

May 03, 2010 10:57 ET

Leatt Restructures South African Branch Office to Improve Efficiency and Profit

CAPE TOWN, SOUTH AFRICA--(Marketwire - May 3, 2010) -  Leatt Corporation (PINKSHEETS: LEAT), a Nevada, USA Corporation headquartered in Cape Town, South Africa, and the developer of the Leatt-Brace®, a Neck Brace System designed to help prevent potentially devastating motor sport injuries to the cervical spine (neck), announced today that Leatt Corporation has restructured its operations to improve the Corporation's performance and improve profitability.

Dr. Leatt, the Chief Executive Officer of Leatt Corporation, said, "After a thorough evaluation of our business and the current market conditions, we have made the difficult decisions required to reposition the company for future growth and profitability. This has involved reducing the number of staff, including one executive operations position, not involved in core product competencies. We plan to outsource non-core activities moving forwards. The duties of the former employees will be or have been transitioned to other employees or agents of the Company. This will hopefully reduce redundancy and overheads. The goal of this process is to refocus on our core competencies and unique position in the marketplace. This strategic restructuring should reduce our financial losses and allow for sustained growth."

About The Leatt Corporation: The Leatt Corporation is the exclusive global distributor of the Leatt-Brace®, a Neck Brace designed to prevent or lessen the severity of potentially devastating motor sport injuries to the cervical spine (neck). The Company is located in Cape Town, South Africa with offices in the U.S. Visit our Company web site at

For more information on the Leatt-Brace®, please visit the company website at Any URL, web site or portion thereof referenced herein is not a part of this press release.

Legal Notice Regarding Forward-Looking Statements: This press release may contain forward-looking statements covered by the Private Securities Litigation Reform Act of 1995 (15 U.S.C. §78j), which are based on the Company's current expectations, forecasts and assumptions. In some cases forward-looking statements may be identified by forward-looking words like "promote," "will," "hopefully," "should," "improve," or similar words. Forward-looking statements involve risks and uncertainties which could cause actual outcomes and results to differ materially from the Company's expectations, forecasts and assumptions. These risks and uncertainties include risks and uncertainties not under the control of the Company, including, without limitation, the current economic climate, market acceptance of our products, the risks of regulatory scrutiny and investigations, vulnerability of the Company and its products to domestic and international competitors with considerably greater resources than the Company and possible inability to establish market share against competing products in many markets, actions of our competitors, the level of demand and market acceptance of our products, and changes in our business strategies. The Company's common stock is quoted on The Pink OTC Market and the Company is a "penny stock company" (as defined under the rules of the Securities Exchange Act of 1934, as amended). The Company is not a reporting company under the U.S. federal securities laws. As such, there are additional, substantial risks associated with the Company and its securities. Such risks include limited liquidity of the Company's common stock, such stock's susceptibility to trading pressure and limitations on ability of broker-dealers to trade or recommend such stock. 

Contact Information